Clinical Trial Detail

NCT ID NCT02796898
Title Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer
Recruitment Completed
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Tyme, Inc
Indications

prostate cancer

Therapies

SM88

Age Groups: adult senior

No variant requirements are available.